Statement from AOPO on Senate Finance Committee Hearing and Report
WASHINGTON–(BUSINESS WIRE)–#AOPO–On August 3rd, the Senate Finance Committee held a hearing and released a report…
WASHINGTON–(BUSINESS WIRE)–#AOPO–On August 3rd, the Senate Finance Committee held a hearing and released a report…
SANTA CLARA, Calif.–(BUSINESS WIRE)–StorPool Storage today announced that it has won the Best of Show…
MINNEAPOLIS–(BUSINESS WIRE)–Northstar Capital (“Northstar”) is pleased to announce its investment in ACI Asphalt & Concrete,…
COSTA MESA, Calif.–(BUSINESS WIRE)–#qsys–QSC, LLC is pleased to announce the promotion of Ronda Ross to…
The Computational Storage Technical Work Group Receives Award for Computational Storage Architecture and Programming Model…
AUSTIN, Texas–(BUSINESS WIRE)–American Campus Communities, Inc. (NYSE:ACC), the largest owner, manager and developer of high-quality…
Company continues to take innovative approach to financial literacy education by highlighting how technology can…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 12 classes of Velocity Commercial Capital 2022-4 (VCC…
SAN FRANCISCO–(BUSINESS WIRE)–Metallicus, a leader in digital assets technologies, today announced the formation of its…
CoreStack’s New State-of-the-Art Office to Advance NextGen Cloud Governance Solution CHENNAI, India & BELLEVUE, Wash.–(BUSINESS…
Intel experts present briefings, theatre sessions and more at Black Hat USA 2022 and The…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA Credit Profile (KCP), a division of KBRA Analytics, releases research on CMBS…
Next-generation CXL VIP and System VIP tools provide faster path to testing and compliance with…
Expands presence in Latin America MAHWAH, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) — Radware (NASDAQ:…
Company announcement – No. 31 / 2022 Zealand Pharma Hosts Conference Call on August 11 at…
MINNEAPOLIS, Aug. 04, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Clinical Trial Now Expands to Fifteen U.S. Trial Sites HOUSTON, Aug. 04, 2022 (GLOBE NEWSWIRE)…
— Company Receives FDA Fast Track Designation for VAX-24 in Adults — — Vaxcyte Completes…
The CANDLE study met its primary endpoint, with 65.4% of patients with recurrent vulvovaginal candidiasis…
WOBURN, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…